On January 3, 2023 Mission Therapeutics ("Mission"), a drug discovery and development company focused on protein homeostasis by selectively inhibiting deubiquitylating enzymes (DUBs), reported that CEO, Dr Anker Lundemose, will present at the upcoming J.P Morgan Healthcare Conference (Press release, Mission Therapeutics, JAN 3, 2023, View Source [SID1234625739]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mission Therapeutics’ presentation will take place at 5pm Wednesday January 11, 2023 in the Golden Gate Room at the Westin St Francis Hotel.

The event, which will take place in San Francisco on 9-12 Jan 2023, is the largest healthcare investment symposium in the industry, and aims to connect global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.

If you would like to meet up with Anker and the team, please contact [email protected].